-
1
-
-
0038051894
-
Nosocomial infections after cardiac surgery in infants and children: Incidence and risk factors
-
Levy I, Ovadia B, Erez E, et al: Nosocomial infections after cardiac surgery in infants and children: Incidence and risk factors. J Hosp Infect 2003; 53:111-116
-
(2003)
J Hosp Infect
, vol.53
, pp. 111-116
-
-
Levy, I.1
Ovadia, B.2
Erez, E.3
-
2
-
-
0041743156
-
Length of stay after infant heart surgery is related to cognitive outcome at age 8 years
-
Newburger JW, Wypij D, Bellinger DC, et al: Length of stay after infant heart surgery is related to cognitive outcome at age 8 years. J Pediatr 2003; 143:67-73
-
(2003)
J Pediatr
, vol.143
, pp. 67-73
-
-
Newburger, J.W.1
Wypij, D.2
Bellinger, D.C.3
-
3
-
-
0023224940
-
Cardiovascular and renal profile of acute peripheral dopaminel-receptor agonism with fenoldopam
-
Gluck Z, Jossen L, Weidmann P, et al: Cardiovascular and renal profile of acute peripheral dopaminel-receptor agonism with fenoldopam. Hypertension 1987; 10:43-54
-
(1987)
Hypertension
, vol.10
, pp. 43-54
-
-
Gluck, Z.1
Jossen, L.2
Weidmann, P.3
-
4
-
-
0032880278
-
The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects
-
Mathur VS, Swan SK, Lambrecht LJ, et al: The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects. Crit Care Med 1999; 27:1832-1837
-
(1999)
Crit Care Med
, vol.27
, pp. 1832-1837
-
-
Mathur, V.S.1
Swan, S.K.2
Lambrecht, L.J.3
-
5
-
-
0035936042
-
Fenoldopam: A selective peripheral dopamine-receptor agonist for the treatment of severe hypertension
-
Murphy MB, Murray C, Shorten GD: Fenoldopam: A selective peripheral dopamine-receptor agonist for the treatment of severe hypertension. N Engl J Med 2001; 345:1548-1557
-
(2001)
N Engl J Med
, vol.345
, pp. 1548-1557
-
-
Murphy, M.B.1
Murray, C.2
Shorten, G.D.3
-
6
-
-
0028789940
-
Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants: A comparison of low-flow cardiopulmonary bypass and circulatory arrest
-
Wernovsky G, Wypij D, Jonas RA, et al: Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants: A comparison of low-flow cardiopulmonary bypass and circulatory arrest. Circulation 1995; 92:2226-2235
-
(1995)
Circulation
, vol.92
, pp. 2226-2235
-
-
Wernovsky, G.1
Wypij, D.2
Jonas, R.A.3
-
7
-
-
0020406343
-
Cardiovascular dopamine receptors: Physiological, pharmacological and therapeutic implications
-
Lokhandwala MF, Barrett RJ: Cardiovascular dopamine receptors: Physiological, pharmacological and therapeutic implications. J Auton Pharmacol 1982; 2:189-215
-
(1982)
J Auton Pharmacol
, vol.2
, pp. 189-215
-
-
Lokhandwala, M.F.1
Barrett, R.J.2
-
8
-
-
0025030307
-
Dopamine inhibits Na(+)-H+ exchanger activity in renal BBMV by stimulation of adenylate cyclase
-
Felder CC, Campbell T, Albrecht F, et al: Dopamine inhibits Na(+)-H+ exchanger activity in renal BBMV by stimulation of adenylate cyclase. Am J Physiol 1990; 259(2 Pt 2):F297-F303
-
(1990)
Am J Physiol
, vol.259
, Issue.2 PART 2
-
-
Felder, C.C.1
Campbell, T.2
Albrecht, F.3
-
9
-
-
0025921477
-
Phosphorylated Mr 32,000 dopamine- and cAMP-regulated phosphoprotein inhibits Na+,K(+)-ATPase activity in renal tubule cells
-
Aperia A, Fryckstedt J, Svensson L, et al: Phosphorylated Mr 32,000 dopamine- and cAMP-regulated phosphoprotein inhibits Na+,K(+)-ATPase activity in renal tubule cells. Proc Nat Acad Sci U S A 1991; 88:2798-2801
-
(1991)
Proc Nat Acad Sci U S A
, vol.88
, pp. 2798-2801
-
-
Aperia, A.1
Fryckstedt, J.2
Svensson, L.3
-
10
-
-
0023855120
-
The effect of selective dopamine-1 receptor stimulation on renal and adrenal function in man
-
Hughes JM, Beck TR, Rose CE Jr, et al: The effect of selective dopamine-1 receptor stimulation on renal and adrenal function in man. J Clin Endocrinol Metab 1988; 66:518-525
-
(1988)
J Clin Endocrinol Metab
, vol.66
, pp. 518-525
-
-
Hughes, J.M.1
Beck, T.R.2
Rose Jr., C.E.3
-
11
-
-
0023899110
-
Pharmacokinetic and pharmacodynamic properties of intravenous fenoldopam, a dopamine1-receptor agonist, in hypertensive patients
-
Weber RR, McCoy CE, Ziemniak JA, et al: Pharmacokinetic and pharmacodynamic properties of intravenous fenoldopam, a dopamine1-receptor agonist, in hypertensive patients. Br J Clin Pharmacol 1988; 25:17-21
-
(1988)
Br J Clin Pharmacol
, vol.25
, pp. 17-21
-
-
Weber, R.R.1
McCoy, C.E.2
Ziemniak, J.A.3
-
12
-
-
0029400025
-
Randomized, prospective trial of fenoldopam vs sodium nitroprusside in the treatment of acute severe hypertension
-
Panacek EA, Bednarczyk EM, Dunbar LM, et al: Randomized, prospective trial of fenoldopam vs sodium nitroprusside in the treatment of acute severe hypertension. Acad Emerg Med 1995; 2:959-965
-
(1995)
Acad Emerg Med
, vol.2
, pp. 959-965
-
-
Panacek, E.A.1
Bednarczyk, E.M.2
Dunbar, L.M.3
-
13
-
-
0034130054
-
Fenoldopam, a dopamine agonist, for hypertensive emergency: A multicenter randomized trial
-
Tumlin JA, Dunbar LM, Oparil S, et al: Fenoldopam, a dopamine agonist, for hypertensive emergency: A multicenter randomized trial. Acad Emerg Med 2000; 7:653-662
-
(2000)
Acad Emerg Med
, vol.7
, pp. 653-662
-
-
Tumlin, J.A.1
Dunbar, L.M.2
Oparil, S.3
-
14
-
-
1942438940
-
Fenoldopam versus nitroprusside for the treatment of hypertensive emergency
-
Devlin JW, Seta ML, Kanji S, et al: Fenoldopam versus nitroprusside for the treatment of hypertensive emergency. Ann Pharmacother 2004; 38:755-759
-
(2004)
Ann Pharmacother
, vol.38
, pp. 755-759
-
-
Devlin, J.W.1
Seta, M.L.2
Kanji, S.3
-
15
-
-
0027520933
-
Intravenous fenoldopam infusion in severe heart failure
-
Patel JJ, Mitha AS, Sareli P, et al: Intravenous fenoldopam infusion in severe heart failure. Cardiovasc Drugs Ther 1993; 7:97-101
-
(1993)
Cardiovasc Drugs Ther
, vol.7
, pp. 97-101
-
-
Patel, J.J.1
Mitha, A.S.2
Sareli, P.3
-
16
-
-
0025099765
-
Assessment of hemodynamic tolerance from a 24-hour intravenous infusion of fenoldopam mesylate in congestive heart failure
-
Munger MA, Benotti JR, Green JA, et al: Assessment of hemodynamic tolerance from a 24-hour intravenous infusion of fenoldopam mesylate in congestive heart failure. Am J Cardiol 1990; 65:206-210
-
(1990)
Am J Cardiol
, vol.65
, pp. 206-210
-
-
Munger, M.A.1
Benotti, J.R.2
Green, J.A.3
-
17
-
-
0037292960
-
A case series of low-dose fenoldopam in seventy cardiac surgical patients at increased risk of renal dysfunction
-
Garwood S, Swamidoss CP, Davis EA, et al: A case series of low-dose fenoldopam in seventy cardiac surgical patients at increased risk of renal dysfunction. J Cardiothorac Vasc Anesth 2003; 17:17-21
-
(2003)
J Cardiothorac Vasc Anesth
, vol.17
, pp. 17-21
-
-
Garwood, S.1
Swamidoss, C.P.2
Davis, E.A.3
-
18
-
-
0035663088
-
Fenoldopam: Renal and splanchnic effects in patients undergoing coronary artery bypass grafting
-
Halpenny M, Lakshmi S, O'Donnell A, et al: Fenoldopam: Renal and splanchnic effects in patients undergoing coronary artery bypass grafting. Anaesthesia 2001; 56:953-960
-
(2001)
Anaesthesia
, vol.56
, pp. 953-960
-
-
Halpenny, M.1
Lakshmi, S.2
O'Donnell, A.3
-
19
-
-
0041856108
-
Fenoldopam for renal protection in patients undergoing cardiopulmonary bypass
-
Caimmi PP, Pagani L, Micalizzi E, et al: Fenoldopam for renal protection in patients undergoing cardiopulmonary bypass. J Cardiothorac Vasc Anes 2003; 17:491-494
-
(2003)
J Cardiothorac Vasc Anes
, vol.17
, pp. 491-494
-
-
Caimmi, P.P.1
Pagani, L.2
Micalizzi, E.3
-
20
-
-
0034757321
-
Fenoldopam infusion associated with preserving renal function after aortic cross-clamping for aneurysm repair
-
Gilbert TB, Hasnain JU, Flinn WR, et al: Fenoldopam infusion associated with preserving renal function after aortic cross-clamping for aneurysm repair. J Cardiovasc Pharmacol Ther 2001; 6:31-36
-
(2001)
J Cardiovasc Pharmacol Ther
, vol.6
, pp. 31-36
-
-
Gilbert, T.B.1
Hasnain, J.U.2
Flinn, W.R.3
-
21
-
-
0037240048
-
Contemporary strategies to preserve renal function during cardiac and vascular surgery
-
Sheinbaum R, Ignacio C, Safi HJ, et al: Contemporary strategies to preserve renal function during cardiac and vascular surgery. Rev Cardiovasc Med 2003; 4:S21-S28
-
(2003)
Rev Cardiovasc Med
, vol.4
-
-
Sheinbaum, R.1
Ignacio, C.2
Safi, H.J.3
-
22
-
-
0242493661
-
Fenoldopam mesylate for the prevention of contrast-induced nephropathy: A randomized controlled trial
-
Stone GW, McCullough PA, Tumlin JA, et al: Fenoldopam mesylate for the prevention of contrast-induced nephropathy: A randomized controlled trial. JAMA 2003; 290:2284-2291
-
(2003)
JAMA
, vol.290
, pp. 2284-2291
-
-
Stone, G.W.1
McCullough, P.A.2
Tumlin, J.A.3
-
23
-
-
4143104704
-
N-Acetylcysteine versus fenoldopam mesylate to prevent contrast agent-associated nephrotoxicity
-
Briguori C, Colombo A, Airoldi F, et al: N-Acetylcysteine versus fenoldopam mesylate to prevent contrast agent-associated nephrotoxicity. J Am Coll Cardiol 2004; 44:762-765
-
(2004)
J Am Coll Cardiol
, vol.44
, pp. 762-765
-
-
Briguori, C.1
Colombo, A.2
Airoldi, F.3
-
25
-
-
0034086044
-
Fenoldopam for controlled hypotension during spinal fusion in children and adolescents
-
Tobias JD: Fenoldopam for controlled hypotension during spinal fusion in children and adolescents. Paediatr Anaesth 2000; 10:261-266
-
(2000)
Paediatr Anaesth
, vol.10
, pp. 261-266
-
-
Tobias, J.D.1
-
26
-
-
0026045030
-
Renal function after cardiopulmonary bypass in children: Comparison of dopamine with dobutamine
-
Wenstone R, Campbell JM, Booker PD, et al: Renal function after cardiopulmonary bypass in children: Comparison of dopamine with dobutamine. Br J Anaesth 1991; 67:591-594
-
(1991)
Br J Anaesth
, vol.67
, pp. 591-594
-
-
Wenstone, R.1
Campbell, J.M.2
Booker, P.D.3
-
27
-
-
0142150306
-
Mannitol and dopamine in patients undergoing cardiopulmonary bypass: A randomized clinical trial
-
Carcoana OV, Mathew JP, Davis E, et al: Mannitol and dopamine in patients undergoing cardiopulmonary bypass: A randomized clinical trial. Anesth Analg 2003; 97:1222-1229
-
(2003)
Anesth Analg
, vol.97
, pp. 1222-1229
-
-
Carcoana, O.V.1
Mathew, J.P.2
Davis, E.3
-
28
-
-
0036839810
-
Postoperative junctional ectopic tachycardia in children: Incidence, risk factors, and treatment
-
Hoffman TM, Bush DM, Wernovsky G, et al: Postoperative junctional ectopic tachycardia in children: Incidence, risk factors, and treatment. Ann Thorac Surg 2002; 74:1607-1611
-
(2002)
Ann Thorac Surg
, vol.74
, pp. 1607-1611
-
-
Hoffman, T.M.1
Bush, D.M.2
Wernovsky, G.3
|